Differences in ERK activation in squamous mucosa in patients who have gastroesophageal reflux disease with and without Barrett's esophagus

American Journal of Gastroenterology

Volumn 100, Issue 3, 2005, Pages 551-559

  Souza, Rhonda F ^a   Shewmake, Kenneth L ^b   Shen, Yuenan ^b   Ramirez, Ruben D ^b   Bullock, Jeff S ^b   Hladik, Christa L ^b   Lee, Edward L ^b   Terada, Lance S ^b   Spechler, Stuart J ^b  

^a VA NORTH TEXAS HEALTH CARE SYSTEM   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HYDROCHLORIC ACID; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3;

ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOSCOPIC BIOPSY; ENZYME ACTIVATION; ENZYME LOCALIZATION; ENZYME PHOSPHORYLATION; FEMALE; GASTROESOPHAGEAL REFLUX; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SQUAMOUS EPITHELIUM; WESTERN BLOTTING;

ADULT; AGED; BARRETT ESOPHAGUS; BIOPSY; BLOTTING, WESTERN; ENZYME ACTIVATION; FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MALE; METAPLASIA; MIDDLE AGED; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MUCOUS MEMBRANE; PHOSPHORYLATION; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION;

EID: 16744369176     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2005.41122.x     Document Type: Article

References (27)

1. Spechler SJ. Clinical practice. Barrett's esophagus. N Engl J Med 2002;346:836-42.
2. Oberg S, Johansson J, Wenner J, et al. Metaplastic columnar mucosa in the cervical esophagus after esophagectomy. Ann Surg 2002;235:338-45.
3. Franchimont D, Covas A, Brasseur C, et al. Newly developed Barrett's esophagus after subtotal esophagectomy. Endoscopy 2003;35:850-3.
4. O'Riordan JM, Tucker ON, Byrne PJ, et al. Factors influencing the development of Barrett's epithelium in the esophageal remnant postesophagectomy. Am J Gastroenterol 2004;99:205-11.
5. Vaezi MF, Richter JE. Role of acid and duodenogastroesophageal reflux in gastroesophageal reflux disease. Gastroenterology 1996;111:1192-9.
6. Whitmarsh AJ, Davis RJ. Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways. J Mol Med 1996;74:589-607.
7. Karin M. The regulation of AP-1 activity by mitogen-activated protein kinases. J Biol Chem 1995;270:16483-6.
8. Xue L, Lucocq JM. Low extracellular pH induces activation of ERK 2, JNK, and p38 in A431 and Swiss 3T3 cells. Biochem Biophys Res Commun 1997;241:236-42.
9. Souza RF, Shewmake K, Terada LS, et al. Acid exposure activates the mitogen-activated protein kinase pathways in Barrett's esophagus. Gastroenterology 2002;122:299-307.
10. Marshall CJ. Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation. Cell 1995;80:179-85.
11. Cowley S, Paterson H, Kemp P, et al. Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell 1994;77:841-52.
12. Clark JA, Frey MR, Black JD. Sustained activation of the MAPK pathway is required for maintainence of PKC-mediated cell cycle withdrawal in intestinal epithelial cells. Proceedings of the American Association for Cancer Research 2001;42:672.
13. Luongo D, Mazzarella G, Della RF, et al. Down-regulation of ERK1 and ERK2 activity during differentiation of the intestinal cell line HT-29. Mol Cell Biochem 2002;231:43-50.
14. Davido DJ, Richter F, Boxberger F, et al. Butyrate and propionate downregulate ERK phosphorylation in HT-29 colon carcinoma cells prior to differentiation. Eur J Cancer Prev 2001;10:313-21.
15. Taupin D, Podolsky DK. Mitogen-activated protein kinase activation regulates intestinal epithelial differentiation. Gastroenterology 1999;116:1072-80.
16. Ding Q, Wang Q, Evers BM. Alterations of MAPK activities associated with intestinal cell differentiation. Biochem Biophys Res Commun 2001;284:282-8.
17. Zweibaum A, Pinto M, Chevalier G, et al. Enterocytic differentiation of a subpopulation of the human colon tumor cell line HT-29 selected for growth in sugar-free medium and its inhibition by glucose. J Cell Physiol 1985;122:21-9.
18. Fitzgerald RC, Omary MB, Triadafilopoulos G. Acid modulation of HT29 cell growth and differentiation. An in vitro model for Barrett's esophagus. J Cell Sci 1997;110 (Pt 5):663-71.
19. Ismail-Beigi F, Horton PF, Pope CE. Histological consequences of gastroesophageal reflux in man. Gastroenterology 1970;58:163-74.
20. Winter HS, Madara JL, Stafford RJ, et al. Intraepithelial eosinophils: A new diagnostic criterion for reflux esophagitis. Gastroenterology 1982;83:818-23.
21. Brown LF, Goldman H, Antonioli DA. Intraepithelial eosinophils in endoscopic biopsies of adults with reflux esophagitis. Am J Surg Pathol 1984;8:899-905.
22. Richter JE, Bradley LA, DeMeester TR, et al. Normal 24-hr ambulatory esophageal pH values. Influence of study center, pH electrode, age, and gender. Dig Dis Sci 1992;37:849-56.
23. Winnan GR, Meyer CT, McCallum RW. Interpretation of the Bernstein test: A reappraisal of criteria. Ann Intern Med 1982;96:320-2.
24. Hopwood D, Logan KR, Bouchier IA. The electron microscopy of normal human oesophageal epithelium. Virchows Arch B Cell Pathol 1978;26:345-58.
25. Schaeffer HJ, Weber MJ. Mitogen-activated protein kinases: Specific messages from ubiquitous messengers. Mol Cell Biol 1999;19:2435-44.
26. Tarnawski AS, Pai R, Wang H, et al. Translocation of MAP (Erk-1 and -2) kinases to cell nuclei and activation of c-fos gene during healing of experimental gastric ulcers. J Physiol Pharmacol 1998;49:479-88.
27. Yoshida K, Kuwano K, Hagimoto N, et al. MAP kinase activation and apoptosis in lung tissues from patients with idiopathic pulmonary fibrosis. J Pathol 2002;198:388-96.